Remove 2020 Remove Doctors Remove Specialization
article thumbnail

Fewer Prescribers Are Driving NBRx Than You Think—Here’s Why

PM360

By 2020, that percentage plummeted to just 8%. While it’s unsurprising that patients flock to these cheaper alternatives to treat common conditions, generic medications aren’t as accessible for specialized conditions, which gives pharma marketers an opportunity to drive scripts where the market is less crowded.

article thumbnail

GoodRx Surpasses $500M in Savings for Americans with Diabetes

PM360

from 2020 to 2023. The cost of diabetes 6 can exceed $5,800 per year when factoring in medications, doctor visits, outpatient care, and self-care to control blood glucose levels. “’Life or death’: Experiences of insulin insecurity among adults with type 1 diabetes in the United States,” SSM Population Health , June 27, 2020.

Doctors 72
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Pandemic Innovators: Pharma Marketing Strategies that Reinvent the In-Person Conversation

Pharmaceutical Representative Training

Before 2020, the landscape of drug marketing involved following drug approvals by the Food and Drug Administration ( FDA ), finding which patient population would benefit from therapy, and visiting specialized doctors in-person to advertise its advantages compared to current guidelines. The technology identifies.

article thumbnail

Women fighting COVID-19 with science: Spotlight on Alex Li

Clarivate

One of the most-cited researchers in her field in 2020-2021, Alex has more than 10 references on risk factors, research on treatments and more on various cancers, diabetes and other diseases and conditions. Before I joined Clarivate in 2020, I was a post-doctoral researcher at Brown University focusing on skin cancer research.

article thumbnail

Preventive Care Awareness and Access is Lagging for LGBTQ+ Patients—But Pharma Can Help

PM360

A 2020 survey from the Center from American Progress found that 15% of LGBTQ+ patients, including 28% of transgender patients, said they had postponed or avoided medical care because of discrimination, and 16% of respondents reported postponing or avoiding preventive screenings for the same reason.

article thumbnail

Biogen’s $900 million settlement signals scrutiny on speaker fees

Pharmaceutical Technology

In 2020, the US Department of Health and Human Services (HHS) Office of Inspector General released a special fraud alert showing its skepticism surrounding speaker programs like those conducted by Biogen for its MS drugs. At the same time, companies need to prioritize their compliance programs. Biogen’s activity in multiple sclerosis.

article thumbnail

Can holograms help in the frontline fight against pharmaceutical counterfeiting?

European Pharmaceutical Review

Indeed, a 2020 operation coordinated by Europol across 27 countries led to the seizure of more than 25 million units of counterfeit anticancer drugs and erectile dysfunction medicines among other fake drugs worth nearly €73 million. An expansive role for holograms… Meditag serialised hologram labels.